Clever Leaves Inc.

AI Score

0

Unlock

0.00
null (null%)
At close: Jan 14, 2025, 8:00 PM

Company Description

Clever Leaves Holdings Inc. operates as a cannabis company.

The company operates through two segments, Cannabinoid and Non-Cannabinoid.

The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally.

The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States.

The company was founded in 2017 and is based in Boca Raton, Florida.

Clever Leaves Inc.
Clever Leaves  Inc. logo
Country United States
IPO Date Dec 18, 2020
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 296
CEO Andres Fajardo

Contact Details

Address:
6501 Congress Avenue
Boca Raton, Florida
United States
Website https://www.cleverleaves.com

Stock Details

Ticker Symbol CLVR
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001819615
CUSIP Number 186760104
ISIN Number CA1867602031
Employer ID 00-0000000
SIC Code 2834

Key Executives

Name Position
Andres Fajardo Co-Founder, Chief Executive Officer & Director
Gustavo Escobar Chief Operating Officer
Henry R. Hague III Chief Financial Officer
Andrew Miller Head of Business Development
Camilo Bohorquez Head of Colombia
Caroline Kliess Managing Director of Germany
Jackie Keshner Investor Relations Executive
Julian Wilches Chief Regulatory Officer
Marta Pinto Leite General Counsel & Corporate Secretary

Latest SEC Filings

Date Type Title
May 21, 2024 3 Filing
May 21, 2024 SC 13D/A [Amend] Filing
May 16, 2024 15-12G Filing
May 15, 2024 SC 13D Filing
May 06, 2024 S-8 POS Filing
May 06, 2024 S-8 POS Filing
May 06, 2024 S-8 POS Filing
May 06, 2024 POS AM Filing
May 06, 2024 25 Filing
Apr 26, 2024 8-K Current Report